Abstract not found

Presented here is a genome sequence of an individual human. It was produced from;32 million random DNA fragments, sequenced by Sanger dideoxy technology and assembled into 4,528 scaffolds, comprising 2,810 million bases (Mb) of contiguous sequence with approximately 7.5-fold coverage for any given

A substantial literature over the past thirty years has evaluated tradeoffs between money and fatality risks. These values in turn serve as estimates of the value of a statistical life. This article reviews more than 60 studies of mortality risk premiums from ten countries and approximately 40

services can be found online on the World Wide Web at: The online version of this article, along with updated information and e152S.DC1.html

The authors would like to thank Donald P. Moss, PhD for his guidance in developing this monograph. They would also like to thank Pam Sherwill, MS, librarian at the University of Florida, for her invaluable assistance in searching the literature for biofeedback articles. Thank you to Robert P. Whitehouse, EdD, for compiling the CPT Treatment Codes. In addition, we would like to thank the following members of the Association for Applied Psychophysiology and Biofeedback who reviewed the monograph prior to publication.

Disclaimer: The opinions expressed in this document are those of the authors and do not reflect the official position of AHRQ or the U.S. Department of Health and Human Services. This document is in the public domain and may be used and reprinted without permission, except those copyrighted materials noted for which further reproduction is prohibited without specific permission of the copyright holder. Citation of the source is appreciated.

of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services. This report is intended as a reference and not as a substitute for clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any

ii ACKNOWLEDGEMENTS On completion of this study, I have many to thank. In particular, Dr Dennis Chang, my principal supervisor, for his guidance and encouragement, and Professor Alan Bensoussan and Professor Daniel Chan, my co-supervisors, for their academic support and instruction during the clinical trial. I wish to acknowledge the financial support provided by the University of Western

The preparation of this revised monograph was achieved with the expert input of the editors, members of the guidelines committee, experts who submitted manuscripts for each section, and many expert reviewers, who are listed at the end of the document. The material in this monograph represents the opinions of the editors and does not represent the official position of the National Academy of Clinical Biochemistry or any of

Psychological science can inform policies and practices that affect the lives and well-being of children and their families. But just because it can, doesn’t mean it does. That’s because potentially useful research sometimes does not get translated into plain language and communicated appropriately to non-psychologists. That’s where Division 37 comes in. We exist for the purpose of translating re-search into policy and action on behalf of children, youth, and their families. We support psychological science. We use research findings to develop and improve programs, services, policies, and practice. We perform advocacy at the local, state, and federal levels to prod those in power to allocate funds for such services. As you will learn from this issue of the Child and Family Policy and Practice Review, these activities are essential for the engaged psychologist,